Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias

Douglas J. Clarke, Nabil Moghrabi, Gemma Monaghan, Andrew Cassidy, Maureen Boxer, Robert Hume, Brian Burchell

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Congenital familial non-haemolytic hyperbilirubinaemias are potentially lethal syndromes caused by genetic lesions that reduce or abolish hepatic bilirubin UDP-glucuronosyltransferase activity. Here we describe genetic defects that occur in the UGT1 gene complex that cause three non-haemolytic unconjugated hyperbilirubinaemia syndromes. The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts. Crigler-Najjar type II syndrome which is treatable with phenobarbital therapy is associated with less dramatic missense mutations or heterozygous expression of mutant and normal alleles. Gilbert's syndrome, the most prevalent (2-19% in population studies) and mildest of the three syndromes is principally caused by a TA insertion at the TATA promoter region upstream of the UGTIA1 exon. Current methods used for the diagnosis and treatment of these diseases are discussed.

Original languageEnglish
Pages (from-to)63-74
Number of pages12
JournalClinica Chimica Acta
Volume266
Issue number1
DOIs
Publication statusPublished - 9 Oct 1997
Externally publishedYes

Fingerprint

Glucuronosyltransferase
Hyperbilirubinemia
bilirubin glucuronoside glucuronosyltransferase
Exons
Genes
Defects
Phenobarbital
Genetic Promoter Regions
Crigler-Najjar Syndrome
Gilbert Disease
Mutation
Terminator Codon
Missense Mutation
Enzymes
Alleles
Liver
Therapeutics
Population

Cite this

Clarke, Douglas J. ; Moghrabi, Nabil ; Monaghan, Gemma ; Cassidy, Andrew ; Boxer, Maureen ; Hume, Robert ; Burchell, Brian. / Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. In: Clinica Chimica Acta. 1997 ; Vol. 266, No. 1. pp. 63-74.
@article{b4780f2854de444cbed0ce23845e817f,
title = "Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias",
abstract = "Congenital familial non-haemolytic hyperbilirubinaemias are potentially lethal syndromes caused by genetic lesions that reduce or abolish hepatic bilirubin UDP-glucuronosyltransferase activity. Here we describe genetic defects that occur in the UGT1 gene complex that cause three non-haemolytic unconjugated hyperbilirubinaemia syndromes. The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts. Crigler-Najjar type II syndrome which is treatable with phenobarbital therapy is associated with less dramatic missense mutations or heterozygous expression of mutant and normal alleles. Gilbert's syndrome, the most prevalent (2-19{\%} in population studies) and mildest of the three syndromes is principally caused by a TA insertion at the TATA promoter region upstream of the UGTIA1 exon. Current methods used for the diagnosis and treatment of these diseases are discussed.",
keywords = "Bilirubin UDP-glucuronosyltransferase, Crigler-Naijar syndrome, Gilbert's syndrome, Mutations, UGT1 gene, Unconjugated hyperbilirubinaemia",
author = "Clarke, {Douglas J.} and Nabil Moghrabi and Gemma Monaghan and Andrew Cassidy and Maureen Boxer and Robert Hume and Brian Burchell",
year = "1997",
month = "10",
day = "9",
doi = "10.1016/S0009-8981(97)00167-8",
language = "English",
volume = "266",
pages = "63--74",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1",

}

Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. / Clarke, Douglas J.; Moghrabi, Nabil; Monaghan, Gemma; Cassidy, Andrew; Boxer, Maureen; Hume, Robert; Burchell, Brian.

In: Clinica Chimica Acta, Vol. 266, No. 1, 09.10.1997, p. 63-74.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias

AU - Clarke, Douglas J.

AU - Moghrabi, Nabil

AU - Monaghan, Gemma

AU - Cassidy, Andrew

AU - Boxer, Maureen

AU - Hume, Robert

AU - Burchell, Brian

PY - 1997/10/9

Y1 - 1997/10/9

N2 - Congenital familial non-haemolytic hyperbilirubinaemias are potentially lethal syndromes caused by genetic lesions that reduce or abolish hepatic bilirubin UDP-glucuronosyltransferase activity. Here we describe genetic defects that occur in the UGT1 gene complex that cause three non-haemolytic unconjugated hyperbilirubinaemia syndromes. The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts. Crigler-Najjar type II syndrome which is treatable with phenobarbital therapy is associated with less dramatic missense mutations or heterozygous expression of mutant and normal alleles. Gilbert's syndrome, the most prevalent (2-19% in population studies) and mildest of the three syndromes is principally caused by a TA insertion at the TATA promoter region upstream of the UGTIA1 exon. Current methods used for the diagnosis and treatment of these diseases are discussed.

AB - Congenital familial non-haemolytic hyperbilirubinaemias are potentially lethal syndromes caused by genetic lesions that reduce or abolish hepatic bilirubin UDP-glucuronosyltransferase activity. Here we describe genetic defects that occur in the UGT1 gene complex that cause three non-haemolytic unconjugated hyperbilirubinaemia syndromes. The most severe syndrome, termed Crigler-Najjar syndrome type I, is mainly associated with mutations in exons 2 to 5 that affect all UGT1 enzymes and many of the mutations result in termination codons and frameshifts. Crigler-Najjar type II syndrome which is treatable with phenobarbital therapy is associated with less dramatic missense mutations or heterozygous expression of mutant and normal alleles. Gilbert's syndrome, the most prevalent (2-19% in population studies) and mildest of the three syndromes is principally caused by a TA insertion at the TATA promoter region upstream of the UGTIA1 exon. Current methods used for the diagnosis and treatment of these diseases are discussed.

KW - Bilirubin UDP-glucuronosyltransferase

KW - Crigler-Naijar syndrome

KW - Gilbert's syndrome

KW - Mutations

KW - UGT1 gene

KW - Unconjugated hyperbilirubinaemia

UR - http://www.scopus.com/inward/record.url?scp=0030728222&partnerID=8YFLogxK

U2 - 10.1016/S0009-8981(97)00167-8

DO - 10.1016/S0009-8981(97)00167-8

M3 - Article

VL - 266

SP - 63

EP - 74

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1

ER -